These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12446475)

  • 21. Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatography.
    Wu P; Stenman UH; Pakkala M; Närvänen A; Leinonen J
    Prostate; 2004 Mar; 58(4):345-53. PubMed ID: 14968435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation on core-fucosylated prostate-specific antigen as a refined biomarker for differentiation of benign prostate hyperplasia and prostate cancer of different aggressiveness.
    Lang R; Rolny V; Leinenbach A; Karl J; Swiatek-de Lange M; Kobold U; Schrader M; Krause H; Mueller M; Vogeser M
    Tumour Biol; 2019 Mar; 41(3):1010428319827223. PubMed ID: 30907281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.
    Robert M; Gibbs BF; Jacobson E; Gagnon C
    Biochemistry; 1997 Apr; 36(13):3811-9. PubMed ID: 9092810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production, analysis, and characterization of reference materials for prostate-specific antigen.
    Garg UC; Howanitz JH; Nakamura RM; Plous RH; Eckfeldt JH
    Arch Pathol Lab Med; 1995 Dec; 119(12):1104-8. PubMed ID: 7503657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.
    Tabarés G; Radcliffe CM; Barrabés S; Ramírez M; Aleixandre RN; Hoesel W; Dwek RA; Rudd PM; Peracaula R; de Llorens R
    Glycobiology; 2006 Feb; 16(2):132-45. PubMed ID: 16177264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatic strategies for unambiguous identification of prostate specific antigen in clinical samples.
    Végvári A; Rezeli M; Häkkinen J; Sihlbom C; Carlsohn E; Malm J; Lilja H; Laurell T; Marko-Varga G
    J Proteomics; 2011 Dec; 75(1):202-10. PubMed ID: 21723425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen.
    Christensson A; Lilja H
    Eur J Biochem; 1994 Feb; 220(1):45-53. PubMed ID: 7509746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia.
    Charrier JP; Tournel C; Michel S; Dalbon P; Jolivet M
    Electrophoresis; 1999; 20(4-5):1075-81. PubMed ID: 10344287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum concentrations of prostate-specific antigen measured using immune extraction, trypsin digestion, and tandem mass spectrometry quantification of LSEPAELTDAVK peptide.
    Klee EW; Bondar OP; Goodmanson MK; Trushin SA; Bergstralh EJ; Singh RJ; Anderson NL; Klee GG
    Arch Pathol Lab Med; 2014 Oct; 138(10):1381-6. PubMed ID: 25268201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid.
    Zhang WM; Leinonen J; Kalkkinen N; Dowell B; Stenman UH
    Clin Chem; 1995 Nov; 41(11):1567-73. PubMed ID: 7586544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycosylation of prostate specific antigen and its potential diagnostic applications.
    Vermassen T; Speeckaert MM; Lumen N; Rottey S; Delanghe JR
    Clin Chim Acta; 2012 Oct; 413(19-20):1500-5. PubMed ID: 22722018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of human prostate-specific antigen in a sandwich antibody complex.
    Stura EA; Muller BH; Bossus M; Michel S; Jolivet-Reynaud C; Ducancel F
    J Mol Biol; 2011 Dec; 414(4):530-44. PubMed ID: 22037582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of prostate-specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms.
    Végvári A; Rezeli M; Welinder C; Malm J; Lilja H; Marko-Varga G; Laurell T
    J Proteomics; 2010 Apr; 73(6):1137-47. PubMed ID: 20102753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification of human prostatic-specific antigen (hPSA) from seminal plasma by immunoaffinity chromatography using a monoclonal antibody anti total PSA.
    Pérez L; Zulueta O; Melchor A; Hernández L; López R; Cazanave J; Béquer D
    Hybridoma (Larchmt); 2011 Jun; 30(3):247-51. PubMed ID: 21707359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural characteristics of the N-glycans of two isoforms of prostate-specific antigens purified from human seminal fluid.
    Okada T; Sato Y; Kobayashi N; Sumida K; Satomura S; Matsuura S; Takasaki M; Endo T
    Biochim Biophys Acta; 2001 Feb; 1525(1-2):149-60. PubMed ID: 11342264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison by LC-MS and MALDI-MS of prostate-specific antigen from five commercial sources with certified reference material 613.
    Satterfield MB; Welch MJ
    Clin Biochem; 2005 Feb; 38(2):166-74. PubMed ID: 15642280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of prostate-specific antigen in the chemoprevention of prostate cancer.
    Crawford ED; DeAntoni EP; Ross CA
    J Cell Biochem Suppl; 1996; 25():149-55. PubMed ID: 9027612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standard.
    España F; Sanchez-Cuenca J; Vera CD; Estelles A; Gilabert J
    J Lab Clin Med; 1993 Dec; 122(6):711-9. PubMed ID: 7504042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios.
    Oesterling JE; Jacobsen SJ; Klee GG; Pettersson K; Piironen T; Abrahamsson PA; Stenman UH; Dowell B; Lövgren T; Lilja H
    J Urol; 1995 Sep; 154(3):1090-5. PubMed ID: 7543605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular forms of prostate-specific antigen and their clinical significance].
    Hilz H
    Urologe A; 1995 Jul; 34(4):275-82. PubMed ID: 7545841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.